Single doses of FK506 and OKT3 reduce severity in early experimental acute pancreatitis

European Journal of Surgery

Volumn 166, Issue 9, 2000, Pages 734-741

  Mayer, J M ^a   Laine, V J O ^a   Gezgin, A ^a   Kolodziej, S ^a   Nevalainen, T J ^a   Storck, M ^a   Beger, H G ^a  

^a Department of General Surgery ^*  (Germany)

Author keywords

Immunosuppression; Pancreatitis; Pathophysiology; Pulmonary damage; Systemic complications; Treatment

Indexed keywords

AMYLASE; CERULETIDE; INTERLEUKIN 6; MYELOPEROXIDASE; OKT 3; ORTHOCLONE; SODIUM CHLORIDE; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; HEMOCONCENTRATION; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0033824412     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: 10.1080/110241500750008501     Document Type: Article

References (33)

1. Natural course of acute pancreatitis
2. The effects of neutrophil depletion on a completely noninvasive model of acute pancreatitis-associated lung injury
3. Decreased interleukin 2 production in murine acute pancreatitis: Potential for immunomodulation
4. Effects of FK 506 on exocrine pancreas in rats
5. Severe acute pancreatitis: Pathophysiologic mechanisms underlying pancreatic necrosis and remote organ damage
6. Effects of cyclosporine and tacrolimus (FK 506) on acute pancreatitis in mice
7. Effect of different immunosuppressive agents on acute pancreatitis
8. Role of neutrophils in cerulein-induced pancreatitis in rats: Possible involvement of apoptosis
9. Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-alpha polyclonal antibody
10. Value of early blood Th-1 cytokine determination in predicting severity of acute pancreatitis
11. Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis
12. Acute pancreatitis induced by cyclosporine A under stimulation of pancreas by cerulein
13. Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice
14. Cytokines and acute pancreatitis
15. The effects of glucocorticoids and a glucocorticoid antagonist (RU 38486) on experimental acute pancreatitis in rat
16. Mortality from acute pancreatitis
17. Systemic lymphocyte activation modulates the severity of diet-induced acute pancreatitis in mice
18. Local and systemic cytokines in human acute pancreatitis: Clinical and pathophysiologic implications
19. The role of cytokines in the pathogenesis of acute pancreatitis
20. Decreased mortality of severe acute pancreatitis after proximal cytokine blockade
21. IT 9302, a synthetic interleukin 10 agonist, diminishes acute lung injury in rabbits with acute necrotizing pancreatitis
22. Interleukin 10 reduces the severity of acute pancreatitis in rats
23. The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis
24. Reperfusion injury after intestinal ischaemia
25. Role of immunosuppression in the complex treatment of acute pancreatitis
26. Nosocomial sepsis associated with interleukin-2
27. Effect of temporary ischemia upon development and histological patterns of acute pancreatitis in the rat
28. Interleukin 1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model
29. Liver, kidney and thoracic organ transplantation under FK506
30. Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice
31. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis
32. Specific therapy for local and systemic complications of acute pancreatitis with monoclonal antibodies against ICAM-1
33. Macrophage pacification reduces rodent pancreatitis-induced hepatocellular injury through down-regulation of hepatic tumor necrosis factor alpha and interleukin-1 beta